Haemonetics (HAE) Total Liabilities (2010 - 2026)

Haemonetics has reported Total Liabilities for 17 years, with the latest figure at $1.5 billion in Q2 2026.

• On a quarterly basis, Total Liabilities fell 3.26% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 3.26% decrease from a year earlier, with the FY2026 full-year figure at $1.6 billion, down 1.87% from the prior year.
• Total Liabilities was $1.5 billion for Q2 2026 at Haemonetics, down from $1.6 billion in the prior quarter.
• The five-year high for Total Liabilities was $1.6 billion in Q3 2024, with the low at $1.1 billion in Q3 2022.
• Average Total Liabilities over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2023.
• The largest YoY upside for Total Liabilities was 83.77% in 2022 against a maximum downside of 6.0% in 2022.
• Over 5 years, Total Liabilities stood at $1.1 billion in 2022, then climbed by 14.07% to $1.3 billion in 2023, then climbed by 29.22% to $1.6 billion in 2024, then dropped by 2.77% to $1.6 billion in 2025, then slipped by 3.24% to $1.5 billion in 2026.
• The last three Total Liabilities figures came in at $1.5 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.